Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
lol are you really arguing against that sentence?
i think i’m done with this whole thread. nice talking to you all
Yeah - you just want to slut and fat shame people while feeling superior. Best you leave the convo anyway.